Press Release

India Minimally Invasive Biopsy Techniques Market to Grow with a CAGR of 10.77% through 2030

Increasing awareness and early diagnosis is expected to drive the India Minimally Invasive Biopsy Techniques Market growth in the forecast period, 2026-2030.

 

According to TechSci Research report, “India Minimally Invasive Biopsy Techniques Market - By Region, Competition, Forecast & Opportunities, 2030F”, the India Minimally Invasive Biopsy Techniques Market stood at USD 89.31 Million in 2024 and is anticipated to grow with a CAGR of 10.77% through 2030. The Indian government has launched several initiatives to enhance early cancer detection, healthcare accessibility, and diagnostic advancements, fueling the growth of the Minimally Invasive Biopsy Techniques Market. Ayushman Bharat-Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) provides free cancer screening and treatment for millions, ensuring better access to diagnostic services. The National Cancer Control Programme (NCCP) focuses on preventive strategies, early detection, and infrastructure development to combat the rising cancer burden. T

he National Digital Health Mission (NDHM) is improving patient data management and remote diagnostics, accelerating the adoption of liquid biopsies and image-guided techniques. The Make in India initiative is also encouraging domestic production of biopsy instruments and consumables, reducing dependency on imports. Moreover, increased funding for AI-driven diagnostics and public-private partnerships are driving technological advancements, making minimally invasive biopsy techniques more accessible and efficient across India.

The growing awareness about cancer and the importance of early diagnosis is a key driver of the Minimally Invasive Biopsy Techniques Market in India. With rising cancer cases—one in nine Indians likely to develop cancer in their lifetime—there is an increasing emphasis on early detection to improve survival rates. Awareness campaigns by government bodies, healthcare institutions, and non-profit organizations have played a significant role in educating the public about the benefits of regular screenings and advanced diagnostic techniques.

Initiatives such as the National Cancer Awareness Day, the Ayushman Bharat program, and the National Cancer Grid have helped promote preventive healthcare measures and routine check-ups, leading to higher demand for minimally invasive biopsy techniques. The Indian Council of Medical Research (ICMR) and the National Health Mission (NHM) have strengthened cancer registry programs, ensuring improved cancer surveillance and early intervention strategies.

 

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "India Minimally Invasive Biopsy Techniques Market


The India Minimally Invasive Biopsy Techniques Market is segmented into product, technique, circulating biomarker, application, end user, regional distribution, and company.

Based on Product, Instruments have emerged as the fastest growing segment in the India Minimally Invasive Biopsy Techniques Market in 2024, driven by technological advancements, increasing adoption of image-guided procedures, and rising demand for precision diagnostics. The growing burden of cancer cases, coupled with expanding healthcare infrastructure, has fueled the need for biopsy needles, vacuum-assisted biopsy devices, and robotic-assisted systems.

Based on Region, South India have emerged as the fastest growing region in the India Minimally Invasive Biopsy Techniques Market in 2024. This growth is driven by expanding healthcare infrastructure, the presence of leading cancer research institutes, and increasing government investments in diagnostic advancements. States like Tamil Nadu, Karnataka, Telangana, and Kerala are witnessing rapid adoption of minimally invasive biopsy technologies, supported by high-tech medical facilities, a strong private healthcare sector, and rising awareness of early cancer detection. Medical tourism, AI-driven diagnostic innovations, and the growing presence of top-tier hospitals have further fueled market expansion in this region.

 

Major companies operating in India Minimally Invasive Biopsy Techniques Market are:

  • Hoffmann-La Roche AG
  • Thermo Fisher Scientific, Inc.
  • PerkinElmer Inc.
  • QIAGEN India Pvt. Ltd.
  • Cardinal Health International India Pvt Ltd
  • B. Braun SE

 

Download Free Sample Report

Customers can also request for 10% free customization on this report

 

“The field of biopsy procedures has undergone remarkable progress, enhancing accuracy, efficiency, and patient comfort. The adoption of image-guided techniques, such as ultrasound-guided, MRI-guided, and CT-guided biopsies, has significantly improved the precision of tissue sampling, reducing the need for repeat procedures. The emergence of liquid biopsy has transformed cancer diagnostics by enabling non-invasive detection of circulating tumor DNA (ctDNA), making early detection and real-time monitoring of cancer more accessible”, said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

India Minimally Invasive Biopsy Techniques Market By Product (Tests, Kits & Consumables, Instruments), By Technique (Liquid Biopsy, Optical Biopsy, Brush Biopsy, Pigmented Lesion Assays, Others), By Circulating Biomarker (Circulating Tumor Cells (CTCs), Cell Free DNA (cfDNA), Circulating Tumor DNA (ctDNA), Extracellular Vesicles, Others), By Application (Clinical, Therapeutic), By End User (Hospitals & Clinics, Ambulatory Care Center, Academic & Research Institutions), By Region, Competition, Forecast & Opportunities, 2020-2030F”, has evaluated the future growth potential of India Minimally Invasive Biopsy Techniques Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in India Minimally Invasive Biopsy Techniques Market.

 

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: sales@techsciresearch.com

Website: www.techsciresearch.com

Relevant News